Valuation: Medios AG

Market Cap 295M 336M 272M 252M 477M 32.21B 487M 3.27B 1.27B 15.76B 1.26B 1.24B 54.72B P/E 2026 *
10.9x
P/E 2027 * 8.62x
Enterprise Value 371M 423M 343M 317M 600M 40.52B 612M 4.12B 1.6B 19.83B 1.59B 1.55B 68.84B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.16x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day-0.17%
1 week-1.49%
Current month-1.16%
1 month-3.71%
3 months-7.59%
6 months-19.54%
Current year-17.54%
1 week 11.8
Extreme 11.8
13
1 month 11.8
Extreme 11.8
13
Current year 11.64
Extreme 11.64
17.44
1 year 11.64
Extreme 11.64
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap.
02-04Sell

Chief Executive Officer

13,638 0.0535%
01-22Buy

Executive/Senior Manager

4,000 0.0157%
19/08/24Buy

Executive/Senior Manager

10,000 0.0392%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-1.49%-8.29%-27.46% 337M
-0.60%+2.87%+57.65%+170.54% 1,102B
-0.25%+4.86%+70.94%+66.96% 643B
-0.40%+0.99%+33.60%+88.52% 450B
-1.35%+1.86%+29.96%+26.26% 336B
-0.71%+0.72%+28.85%+46.77% 288B
-1.31%-0.26%-28.18%-39.13% 222B
+0.31%+2.00%+24.09%+64.00% 199B
-0.52%+7.36%+21.77%+78.68% 169B
+0.73%+1.57%-5.33%-32.02% 137B
Average -0.44%+2.00%+22.51%+44.31% 354.55B
Weighted average by Cap. -0.54%+2.07%+40.65%+86.32%

Financials

2026 *2027 *
Net sales 2.08B 2.37B 1.92B 1.78B 3.37B 227B 3.43B 23.1B 8.98B 111B 8.91B 8.72B 386B 2.14B 2.44B 1.97B 1.82B 3.46B 233B 3.53B 23.73B 9.22B 114B 9.15B 8.95B 397B
Net income 27.41M 31.25M 25.3M 23.38M 44.32M 2.99B 45.2M 304M 118M 1.46B 117M 115M 5.08B 34.51M 39.34M 31.86M 29.44M 55.8M 3.77B 56.92M 383M 149M 1.84B 148M 145M 6.4B
Net Debt 76.15M 86.82M 70.31M 64.97M 123M 8.31B 126M 845M 328M 4.07B 326M 319M 14.12B 40.72M 46.43M 37.6M 34.74M 65.85M 4.45B 67.17M 452M 176M 2.18B 174M 171M 7.55B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
993
Date Price Change Volume
08/07/26 11.94 -0.83% 21,845
07/07/26 €12.04 -3.22% 17,156
06/07/26 €12.44 +0.16% 29,760
03/07/26 €12.42 +1.47% 10,480
02/07/26 €12.24 +0.99% 12,984
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.04EUR
Average target price
23.00EUR
Spread / Average Target
+91.03%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock